Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Inflammatory Bowel Disease IV: Pharmacological Management01:29

Inflammatory Bowel Disease IV: Pharmacological Management

884
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
884
Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal01:22

Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal

2.8K
Erythropoietin-producing hepatocellular carcinoma receptor (Eph) and its ligand, Eph receptor-interacting protein (Ephrin) were first discovered in the human carcinoma cell line, hence the name. Ephrin-Eph interaction guides cells to reach their appropriate location in adult tissues. They also play an essential role in the immune system by helping in immune cell migration, adhesion, and activation. Based on their structure and function, Eph is divided into two classes — EphA and EphB.
2.8K
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF01:24

Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF

692
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
692
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

994
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
994
Chronic Bowel Disorders: Introduction01:17

Chronic Bowel Disorders: Introduction

869
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
869
Irritable Bowel Syndrome I: Introduction01:17

Irritable Bowel Syndrome I: Introduction

1.3K
Irritable Bowel Syndrome (IBS) is characterized by functional disturbances in the gastrointestinal system, presenting a cluster of symptoms without evident structural or biochemical abnormalities. It primarily affects the large intestine and may cause abdominal pain, bloating, excessive gas, diarrhea, constipation, or both.
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
1.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same authorSame journal

Evaluation of the Anti-Inflammatory and Antioxidant Properties of <i>Mangifera indica</i> var. <i>teloor</i> Extract.

Preventive nutrition and food science·2026
Same author

Hydrolyzed Keratin Peptide Enhances Hair Condition and Promotes Hair Regeneration.

Journal of medicinal food·2026
Same author

The inhibitory effects of <i>Melicope pahangenesis</i> T. G. Hartley extract on LPS-induced acute lung injury.

Food science and biotechnology·2026
Same author

<i>Cinnamomum longepetiolatum</i> (Kosterm.) Extract Modulates Inflammatory Responses and Oxidative Stress in Lipopolysaccharide-Stimulated RAW 264.7 Macrophages.

Preventive nutrition and food science·2025
Same author

Validation of the High-Performance Liquid Chromatography Method for Determining Quercitrin in <i>Capsicum annuum</i> L. Cultivar Dangjo.

Preventive nutrition and food science·2025
Same author

Dietary protocatechuic acid redistributes tight junction proteins by targeting Rho-associated protein kinase to improve intestinal barrier function.

Food & function·2023

Related Experiment Video

Updated: Mar 13, 2026

An Intravital Microscopy-Based Approach to Assess Intestinal Permeability and Epithelial Cell Shedding Performance
07:32

An Intravital Microscopy-Based Approach to Assess Intestinal Permeability and Epithelial Cell Shedding Performance

Published on: December 3, 2020

6.5K

Therapeutic Potential of Ruberythric Acid in Intestinal Inflammation and Barrier Function Reduction.

Hyeon Jeong Jo1, San Kim1, Sung Keun Jung1,2

  • 1School of Food Science and Biotechnology, Kyungpook National University, Daegu 41566, Korea.

Preventive Nutrition and Food Science
|March 12, 2026
PubMed
Summary
This summary is machine-generated.

Ruberythric acid (RBA) may help prevent inflammatory bowel disease (IBD) by improving intestinal barrier function. This natural compound regulates gut permeability and tight junction proteins via the NF-κB pathway.

Keywords:
NF-kappa Binflammatory bowel diseasemyosin-light-chain kinaseruberythric acidtight junctions

More Related Videos

Analyzing Beneficial Effects of Nutritional Supplements on Intestinal Epithelial Barrier Functions During Experimental Colitis
08:58

Analyzing Beneficial Effects of Nutritional Supplements on Intestinal Epithelial Barrier Functions During Experimental Colitis

Published on: January 5, 2017

13.0K
Mechanistic Insight into the Development of TNBS-Mediated Intestinal Fibrosis and Evaluating the Inhibitory Effects of Rapamycin
10:21

Mechanistic Insight into the Development of TNBS-Mediated Intestinal Fibrosis and Evaluating the Inhibitory Effects of Rapamycin

Published on: September 12, 2019

7.8K

Related Experiment Videos

Last Updated: Mar 13, 2026

An Intravital Microscopy-Based Approach to Assess Intestinal Permeability and Epithelial Cell Shedding Performance
07:32

An Intravital Microscopy-Based Approach to Assess Intestinal Permeability and Epithelial Cell Shedding Performance

Published on: December 3, 2020

6.5K
Analyzing Beneficial Effects of Nutritional Supplements on Intestinal Epithelial Barrier Functions During Experimental Colitis
08:58

Analyzing Beneficial Effects of Nutritional Supplements on Intestinal Epithelial Barrier Functions During Experimental Colitis

Published on: January 5, 2017

13.0K
Mechanistic Insight into the Development of TNBS-Mediated Intestinal Fibrosis and Evaluating the Inhibitory Effects of Rapamycin
10:21

Mechanistic Insight into the Development of TNBS-Mediated Intestinal Fibrosis and Evaluating the Inhibitory Effects of Rapamycin

Published on: September 12, 2019

7.8K

Area of Science:

  • Gastroenterology
  • Molecular Biology
  • Pharmacology

Background:

  • Inflammatory bowel disease (IBD) is a chronic gastrointestinal disorder with increasing global prevalence.
  • Pathogen-activated inflammatory mechanisms contribute to IBD pathogenesis.
  • Ruberythric acid (RBA), a compound from *Rubia cordifolia*, has traditional uses but its role in IBD is unknown.

Purpose of the Study:

  • To investigate the potential of Ruberythric acid (RBA) in preventing inflammatory bowel disease (IBD).
  • To determine if RBA affects intestinal permeability and tight junction protein localization.
  • To elucidate the molecular mechanisms underlying RBA's effects on intestinal inflammation.

Main Methods:

  • Caco-2 cell model used to evaluate RBA's effect on intestinal permeability.
  • Lipopolysaccharide (LPS) and tumor necrosis factor-alpha (TNF-α) used to induce inflammatory responses.
  • Analysis of tight junction protein localization and the NF-κB signaling pathway.

Main Results:

  • RBA dose-dependently inhibited LPS- and TNF-α-induced increases in intestinal permeability.
  • RBA attenuated the altered localization of tight junction proteins caused by LPS and TNF-α.
  • RBA inhibited tight junction redistribution by modulating the NF-κB-MLCK pathway.

Conclusions:

  • RBA demonstrates potential in alleviating inflammatory mechanisms relevant to IBD.
  • RBA regulates intestinal permeability and tight junction protein localization.
  • RBA's modulation of the NF-κB pathway suggests its utility as a nutraceutical for IBD treatment.